Records containing: Hypothalamic Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-12A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity
-
CLINICAL_TRIALS study record update · 2026-02-12A Randomized, Placebo-controlled, Double-Blind Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity, With an Open-Label Extension
-
CLINICAL_TRIALS study record update · 2026-02-10A Long-Term, Open-Label Extension Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
-
CLINICAL_TRIALS study record update · 2025-12-22A Study of RM-718 Weekly Formulation in Healthy Subjects With Obesity and in Patients With Obesity Due to MC4R Impairment
-
CLINICAL_TRIALS study record update · 2025-09-16The Effects of Tirzepatide in Young Adults With Prader-Willi Syndrome, Hypothalamic Obesity and General Non-Syndromic Obesity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-28Phentermine/Topiramate in Children, Adolescents, and Young Adults With Hypothalamic Obesity: a Pilot and Feasibility Study
-
CLINICAL_TRIALS study record update · 2025-07-02A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients With Acquired Hypothalamic Obesity
-
CLINICAL_TRIALS study record update · 2024-04-09Identification and Clinical Relevance of an Oxytocin Deficient State Following Melatonin Administration in Patients With Hypopituitarism: a Proof-of-concept, Physiopathological Study With a Control Group
-
CLINICAL_TRIALS study record update · 2024-01-23The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
-
CLINICAL_TRIALS study record update · 2023-09-21A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
-
CLINICAL_TRIALS study record update · 2022-12-13A Phase 2b, Double-blind, Randomized, Placebo-controlled, Dose-finding, Multi-center, 36-week Safety and Efficacy Study With Open-label Extension (OLE) Period of Tesomet in Subjects With Hypothalamic Obesity
-
CLINICAL_TRIALS study record update · 2022-10-05Intranasal Oxytocin to Promote Weight Loss in Children, Adolescents, and Adults With Brain Tumors and Hypothalamic Obesity Syndrome
-
CLINICAL_TRIALS study record update · 2022-05-05Glucagon-Like Peptide-1 Agonist Effects on Energy Balance in Hypothalamic Obesity
-
CLINICAL_TRIALS study record update · 2020-11-02Deep Brain Stimulation for Hypothalamic Obesity: A Surgical & Neuroimaging Study
-
CLINICAL_TRIALS study record update · 2018-10-16Multicentre Double-blind Randomized Clinical Trial Assessing Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
-
CLINICAL_TRIALS study record update · 2018-09-17Individual Nutritional Support at Home for Patients With Hypothalamic Obesity: Efficacy on Eating Behavior, Physical Activity, Physical Abilities, Weight Gain and Quality of Life
-
CLINICAL_TRIALS study record update · 2017-11-17Combined Diazoxide and Metformin Therapy in Children With Hypothalamic Obesity Secondary to Craniopharyngioma: A Pilot Study
-
CLINICAL_TRIALS study record update · 2016-03-21Effects of Exenatide on Hypothalamic Obesity
-
CLINICAL_TRIALS study record update · 2013-10-22Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
-
CLINICAL_TRIALS study record update · 2012-04-30A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients